These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

261 related articles for article (PubMed ID: 2512039)

  • 1. The role of chronic anovulation in the polycystic ovary syndrome: normalization of sex-hormone-binding globulin levels after clomiphene-induced ovulation.
    Eden JA; Place J; Carter GD; Alaghband-Zadeh J; Pawson ME
    Clin Endocrinol (Oxf); 1989 Mar; 30(3):323-32. PubMed ID: 2512039
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Blood flow changes in the ovarian and uterine arteries in women with polycystic ovary syndrome who respond to clomiphene citrate: correlation with serum hormone concentrations.
    Zaidi J; Jacobs H; Campbell S; Tan SL
    Ultrasound Obstet Gynecol; 1998 Sep; 12(3):188-96. PubMed ID: 9793191
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Induction of ovulation with clomiphene citrate in women with polycystic ovary syndrome: the difference between responders and nonresponders.
    Polson DW; Kiddy DS; Mason HD; Franks S
    Fertil Steril; 1989 Jan; 51(1):30-4. PubMed ID: 2491994
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Changing pituitary reactivity to follicle-stimulating hormone and luteinizing hormone-releasing hormone after induced ovulatory cycles and after anovulation in patients with polycystic ovarian disease.
    Blankstein J; Rabinovici J; Goldenberg M; Shaley J; Mehta A; Serr DM; Mashiach S
    J Clin Endocrinol Metab; 1987 Dec; 65(6):1164-7. PubMed ID: 3119650
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ovulation induction in clomiphene-resistant anovulatory women: differential follicular response to purified urinary follicle-stimulating hormone (FSH) versus purified urinary FSH and luteinizing hormone.
    Hoffman DI; Lobo RA; Campeau JD; Tsai HM; Holmberg EA; Ono T; Frederick JJ; Platt LD; diZerega GS
    J Clin Endocrinol Metab; 1985 May; 60(5):922-7. PubMed ID: 3920235
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Women with clomiphene citrate resistant polycystic ovarian disease: predictors of spontaneous ovulation after laparoscopic ovarian drilling.
    Abuelghar WM; Bayoumy HA; Ellaithy MI; Khalil MS
    Eur J Obstet Gynecol Reprod Biol; 2014 Apr; 175():178-85. PubMed ID: 24576485
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Monitoring of ovulation induction.
    Wu CH
    Fertil Steril; 1978 Dec; 30(6):617-30. PubMed ID: 729822
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Changes in serum markers of patients with PCOS during consecutive clomiphene stimulation cycles: a retrospective study.
    Hager M; Hörath S; Frigo P; Koch M; Marculescu R; Ott J
    J Ovarian Res; 2019 Oct; 12(1):91. PubMed ID: 31585548
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Improved treatment for anovulation in polycystic ovarian disease utilizing the effect of progesterone on the inappropriate gonadotrophin release and clomiphene response.
    Homburg R; Weissglas L; Goldman J
    Hum Reprod; 1988 Apr; 3(3):285-8. PubMed ID: 3131386
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of the inappropriate gonadotropin secretion in polycystic ovary syndrome.
    Rebar R; Judd HL; Yen SS; Rakoff J; Vandenberg G; Naftolin F
    J Clin Invest; 1976 May; 57(5):1320-9. PubMed ID: 770505
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pulsatile luteinizing hormone secretion in women with polycystic ovary syndrome under clomiphene citrate. Differences between responders and nonresponders.
    Sir-Petermann T; Alba F; Cohen P; Pacheco J; Devoto L; Rossmanith W
    Exp Clin Endocrinol; 1990 Sep; 96(1):45-51. PubMed ID: 2126241
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ovulation induction with pulsatile luteinizing releasing hormone in women with clomiphene citrate-resistant polycystic ovary-like disease: clinical results.
    Burger CW; Korsen TJ; Hompes PG; van Kessel H; Schoemaker J
    Fertil Steril; 1986 Dec; 46(6):1045-54. PubMed ID: 3096792
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hypothalamic-pituitary-ovarian response to clomiphene citrate in women with polycystic ovary syndrome.
    Kettel LM; Roseff SJ; Berga SL; Mortola JF; Yen SS
    Fertil Steril; 1993 Mar; 59(3):532-8. PubMed ID: 8458453
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of the effects of ovarian cauterization and gonadotropin-releasing hormone agonist and oral contraceptive therapy combination on endocrine changes in women with polycystic ovary disease.
    Taskin O; Yalcinoglu AI; Kafkasli A; Burak F; Ozekici U
    Fertil Steril; 1996 Jun; 65(6):1115-8. PubMed ID: 8641482
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Induction of ovulation by prolonged pulsatile administration of luteinizing hormone releasing hormone (LRH) in patients with clomiphene resistant polycystic ovary-like disease.
    Burger CW; van Kessel H; Schoemaker J
    Acta Endocrinol (Copenh); 1983 Nov; 104(3):357-64. PubMed ID: 6415997
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The independent effects of polycystic ovary syndrome and obesity on serum concentrations of gonadotrophins and sex steroids in premenopausal women.
    Holte J; Bergh T; Gennarelli G; Wide L
    Clin Endocrinol (Oxf); 1994 Oct; 41(4):473-81. PubMed ID: 7955458
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Induction of ovulation by Sairei-to for polycystic ovary syndrome patients.
    Sakai A; Kondo Z; Kamei K; Izumi S; Sumi K
    Endocr J; 1999 Feb; 46(1):217-20. PubMed ID: 10426590
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clomiphene and dexamethasone in women unresponsive to clomiphene alone.
    Lobo RA; Paul W; March CM; Granger L; Kletzky OA
    Obstet Gynecol; 1982 Oct; 60(4):497-501. PubMed ID: 6214735
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A randomized controlled trial of the efficacy of rosiglitazone and clomiphene citrate versus metformin and clomiphene citrate in women with clomiphene citrate-resistant polycystic ovary syndrome.
    Rouzi AA; Ardawi MS
    Fertil Steril; 2006 Feb; 85(2):428-35. PubMed ID: 16595222
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clomiphene citrate reduces serum insulin-like growth factor I and increases sex hormone-binding globulin levels in women with polycystic ovary syndrome.
    Bützow TL; Kettel LM; Yen SS
    Fertil Steril; 1995 Jun; 63(6):1200-3. PubMed ID: 7750589
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.